Baxter International IncNYSE:BAX
- LAST PRICE36.0250
- TODAY'S CHANGE (%)0.1550 (0.4321%)
- Bid / Lots36.0200/ 1
- Ask / Lots36.0300/ 2
- Open / Previous Close36.0100 / 35.8700
- Day Range
- 52 Week Range
- Volume547,430
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BAX |
|---|---|---|
| 09:32 ET | 30055 | 36.01 |
| 09:33 ET | 1508 | 36.18 |
| 09:35 ET | 720 | 36.085 |
| 09:37 ET | 3110 | 36.15 |
| 09:39 ET | 2085 | 36.1 |
| 09:42 ET | 2012 | 36.095 |
| 09:44 ET | 1466 | 36.12 |
| 09:46 ET | 7608 | 36.02 |
| 09:48 ET | 5504 | 36.02 |
| 09:50 ET | 2715 | 36.06 |
| 09:51 ET | 4096 | 36.005 |
| 09:53 ET | 21277 | 36.005 |
| 09:55 ET | 43640 | 35.95 |
| 09:57 ET | 19817 | 35.98 |
| 10:00 ET | 15563 | 36.06 |
| 10:02 ET | 18309 | 36.08 |
| 10:04 ET | 5563 | 36.18 |
| 10:06 ET | 6138 | 36.06 |
| 10:08 ET | 16919 | 36.03 |
| 10:09 ET | 2100 | 36.03 |
| 10:11 ET | 1174 | 36.07 |
| 10:13 ET | 3745 | 36.055 |
| 10:15 ET | 10830 | 36.065 |
| 10:18 ET | 2613 | 36.05 |
| 10:20 ET | 3065 | 36.025 |
| 10:22 ET | 5123 | 36.03 |
| 10:24 ET | 2940 | 36.025 |
| 10:26 ET | 5542 | 36.05 |
| 10:27 ET | 1811 | 36.02 |
| 10:29 ET | 2105 | 36.01 |
| 10:31 ET | 1938 | 36.005 |
| 10:33 ET | 3823 | 36.04 |
| 10:36 ET | 3791 | 36.02 |
| 10:38 ET | 2100 | 36.0309 |
| 10:40 ET | 13087 | 36.08 |
| 10:42 ET | 26110 | 36.09 |
| 10:44 ET | 2923 | 36.08 |
| 10:45 ET | 4446 | 36.065 |
| 10:47 ET | 2474 | 36.04 |
| 10:49 ET | 3437 | 36.055 |
| 10:51 ET | 1479 | 36.04 |
| 10:54 ET | 1930 | 36.025 |
| 10:56 ET | 1967 | 36.025 |
| 10:58 ET | 5024 | 36.015 |
| 11:00 ET | 3643 | 36.005 |
| 11:02 ET | 12254 | 36 |
| 11:03 ET | 15584 | 36.005 |
| 11:05 ET | 12652 | 36 |
| 11:07 ET | 4275 | 36.0007 |
| 11:09 ET | 2913 | 36.009 |
| 11:12 ET | 5399 | 36.005 |
| 11:14 ET | 26662 | 36.005 |
| 11:16 ET | 2603 | 36 |
| 11:18 ET | 13157 | 36.005 |
| 11:20 ET | 6025 | 36.025 |
Oct 23, 2024
Baxter to Present at UBS Global Healthcare Conference, from 4:15PM ET on Wednesday Oct 23, 2024 by Dow Jones
4:15PM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 22, 2024
DJ Medical Manufacturer, Healthcare Providers Grappling to Replenish IV Supplies -- WSJ, from 1:52PM ET on Tuesday Oct 22, 2024 by Dow Jones
1:52PM ET on Tuesday Oct 22, 2024 by Dow Jones
Oct 16, 2024
Press Release: Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors, from 5:28PM ET on Wednesday Oct 16, 2024 by Dow Jones
5:28PM ET on Wednesday Oct 16, 2024 by Dow JonesBaxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors, from 4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
4:15PM ET on Wednesday Oct 16, 2024 by Dow Jones
Oct 10, 2024
DJ How Hurricane Helene Damage to a Baxter Plant Is Causing a Major Hospital Supply Chain Crisis -- Barrons.com, from 4:15PM ET on Thursday Oct 10, 2024 by Dow Jones
4:15PM ET on Thursday Oct 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Baxter International Inc | 18.3B | -117.5x | --- |
Zimmer Biomet Holdings Inc | 21.4B | 20.5x | --- |
Avantor Inc | 15.2B | 49.5x | --- |
Henry Schein Inc | 8.9B | 26.7x | +2.98% |
Solventum Corp | 12.5B | 11.9x | --- |
STERIS plc | 22.2B | 39.5x | +9.33% |
Company Information
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
Contact Information
- Headquarters
- 1 Baxter Parkway,DEERFIELD, IL, United States 60015
- Phone
- 847-948-2000
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Jose Almeida
- Chief Financial Officer, Executive Vice President, Interim Chief Accounting Officer
- Joel Grade
- Chief Human Resource Officer, Executive Vice President
- Jeanne Mason
- Executive Vice President, General Counsel
- David Rosenbloom
- Executive Vice President and Chief Supply Chain Officer
- James Borzi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.3B |
|---|---|
Revenue (TTM) | $15.0B |
Shares Outstanding | 510.2M |
Dividend Yield | 3.22% |
Annual Dividend Rate | 1.1600 USD |
Ex-Dividend Date | 08-30-24 |
Pay Date | 10-01-24 |
Beta | 0.59 |
EPS | $-0.31 |
Book Value | $16.55 |
P/E Ratio | -117.5x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | 16.5x |
Operating Margin | 1.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
